BIOLINERX
Careers | Contact Us
search

Press Releases
March 17, 2015
Management to hold conference call at 10:00 a.m. EDT
March 11, 2015
Results of experiments with BL-9020, a new antibody treatment, published in PLoS One

March 2, 2015
BL-8040 Phase 2b study, as consolidation treatment for AML patients responding to standard induction treatment, is expected to commence shortly after receipt of regulatory approval, anticipated in next few months
January 6, 2015
Results of Phase 1 trial for BL-8040 expected in Q1 2015
Multiple additional clinical milestones for BL-8040 anticipated in 2015
131-140  Out of  309 Previous
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next